Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Non-Current Debt (2010 - 2022)

Analysis

Cerenome (CNSY) Non-Current Debt (2010 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 882.16 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - 8.96 Bn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 546.77 Mn
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.79 Mn
Sep 30, 2022 4.11 Mn
Jun 30, 2022 4.42 Mn
Mar 31, 2022 4.72 Mn
Dec 31, 2021 5.01 Mn
Jun 30, 2017 7.77 Mn
Mar 31, 2017 9.40 Mn
Dec 31, 2016 11.01 Mn
Sep 30, 2016 12.13 Mn
Jun 30, 2016 13.66 Mn
Mar 31, 2016 15.20 Mn
Dec 31, 2015 16.68 Mn
Sep 30, 2015 14.98 Mn
Jun 30, 2015 16.18 Mn
Mar 31, 2015 15.68 Mn
Dec 31, 2014 18.04 Mn
Sep 30, 2014 20.33 Mn
Jun 30, 2014 19.50 Mn
Mar 31, 2014 21.33 Mn
Dec 31, 2013 23.10 Mn